A360
Key Takeaways✦ Atlas AI
01
Most US states have extended the RSV immunization window for infants through April due to an unusually late-circulating virus.
02
Late March data showed a 7.5% RSV test positivity rate, which is significantly higher than the 5% rate from the same time last year.
03
While often mild, RSV can cause severe illness in infants and toddlers, making the extended immunization period a critical public health measure.
Atlas AI
Health officials in nearly every U.S. state have extended the . The move follows an unseasonably late pattern of respiratory syncytial virus circulation, as recent federal data showed the virus continuing to spread later into spring than is typical.
Respiratory syncytial virus, commonly known as RSV, generally eases as spring approaches. Officials said the current season has not followed that expected trajectory, prompting state health departments to keep protective options available for the youngest children, who face the highest risk of severe outcomes.
Data from the Centers for Disease Control and Prevention (CDC) highlighted the shift. In the third week of March, 7.5% of laboratory tests for RSV were positive nationwide. That compared with a 5% positivity rate during the same period last year, and officials noted that rates were even lower in years before that.
Public health authorities linked the extended immunization window to this sustained transmission. While RSV often resembles a mild cold in adults and older children, it can cause serious illness in infants and very young toddlers, including bronchiolitis and pneumonia. Because their airways are smaller, complications can escalate quickly and may require hospitalization, officials said.
Officials also pointed to broader disruption in RSV seasonality in recent years. The traditional pattern typically runs from fall into spring, with a mid-winter peak followed by a sharp decline. The latest CDC figures suggest that the expected drop-off has been delayed this year, reinforcing the rationale for keeping immunizations available beyond the standard end-of-March timeline.
For healthcare systems, the extension is intended to align prevention efforts with the virus’s current behavior rather than the calendar. By maintaining access through the end of April, states aim to reduce the likelihood of severe pediatric cases during a period when many families and clinicians might otherwise assume RSV risk is fading.
Officials said they will continue tracking RSV activity in the coming weeks. Whether recommendations are pushed further—potentially into May—will depend on whether viral circulation falls back toward more typical off-season levels. For now, the key uncertainty is how quickly positivity rates decline and whether the late-season pattern persists.
